<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05090956</url>
  </required_header>
  <id_info>
    <org_study_id>C11-43</org_study_id>
    <secondary_id>2012-A00288-35</secondary_id>
    <nct_id>NCT05090956</nct_id>
  </id_info>
  <brief_title>Developpement of 3T MRI Protocol</brief_title>
  <acronym>(MISAP)</acronym>
  <official_title>Mise au Point de Protocoles RMN Sur l'Imageur Philips 3T installé Sur le Site du Pavillon Baudot du CHU Purpan à Toulouse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since January 2010, a new magnetic resonance imaging scanner (Philips 3T, Achieva) is&#xD;
      installed on the Baudot Building in Toulouse hospital. This tool, is completely dedicated to&#xD;
      the research. It was installed with sequences RMN supplied by the manufacturer.&#xD;
&#xD;
      Imagers also contain an instrumentation susceptible to evolution and/or to adjustment&#xD;
      (antennas radio frequency, sheath of gradients, elements of physiological monitoring (for&#xD;
      example control of the breath), regulation of the homogeneity of the magnetic field).&#xD;
&#xD;
      This MRI scanner and this instrumentation are used for anatomical examinations or for&#xD;
      paradigms of cognitiveresearch (for example of detection of intellectual activations&#xD;
      following simple stimuli of fingers movement, visual tasks, or of mental processes).&#xD;
&#xD;
      The developpement of this equipment is going to favor the emergence of numerous projects and&#xD;
      new themes, up to there adressed by other techniques (psychophysics, EEG).&#xD;
&#xD;
      To obtain good quality signals and know the practical limits of this imager, it is thus&#xD;
      necessary that the researchers doctors, physicists and engineers, can finalize on volunteers'&#xD;
      significant number, all the sequences RMN necessary for the use of these tools for the&#xD;
      research.&#xD;
&#xD;
      These developments are going to get organized around four main axes:&#xD;
&#xD;
      1 the control of the geometrical distortions (generated by the introduction of an object&#xD;
      within the magnetic field) 2 Optimization of the parameters of sequences to improve the&#xD;
      contrast and the spatial resolution of the obtained images 3 the development of new sequences&#xD;
      4 the feasibility study of the protocols of functional MRI&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 8, 2012</start_date>
  <completion_date type="Actual">January 29, 2020</completion_date>
  <primary_completion_date type="Actual">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>quality of MRI images</measure>
    <time_frame>90 months</time_frame>
    <description>assessment of distortion of MRI images</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">230</enrollment>
  <condition>Healthy</condition>
  <condition>Adult ALL</condition>
  <condition>MRI</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRI exam; The sequences to be performed will be presented to the subject according to the focus to be performed. maximal duration of the exam: 2 hours (including subject set up)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>mri</intervention_name>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Healthy adult, age = 18 years;&#xD;
&#xD;
          -  Visual, hearing , oral or written capacities and expression sufficient for the&#xD;
             suitable realization of the tests;&#xD;
&#xD;
          -  Obtaining of the informed consent of the subject.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects presenting a neurological, psychiatric history;&#xD;
&#xD;
          -  Subjects under chronic medication which can influence the intellectual activity;&#xD;
&#xD;
          -  Subjects presenting a contraindication to the MRI (carriers of a pacemaker, an&#xD;
             implanted material(equipment) activated by an electric, magnetic or mechanical system,&#xD;
             carriers of haemostatic clips of anévrysmes intracérébraux or carotid arteries,&#xD;
             carriers of orthopaedic, claustrophobic implants);&#xD;
&#xD;
          -  Subjects refusing to be informed about the possible presence of an anatomical&#xD;
             anormality;&#xD;
&#xD;
          -  administrative Problems: impossibility to give about the information, no insurance,&#xD;
             refusal to sign the consent, under guardianship subject ;&#xD;
&#xD;
          -  Subjects participating in another protocol • pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Inserm U825</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 7, 2012</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

